Company profile
CardiAction
How identifying the unidentified can reduce the impact of Cardiovascular Disease on our populations and health systems
- Industry
- Hospitals and Health Care
- Employees
- 5
- Headquarters
- Melbourne, VIC
- Founded
- 2017
- LinkedIn followers
- 83
- Office locations
- 3
CardiAction company summary
CardiAction is a company in the Hospitals and Health Care industry, headquartered in Melbourne, VIC, founded in 2017. On LinkedIn the company has around 5 employees and 83 followers. The company lists 3 office locations. Its listed specialties include Health Screening, Cardiovascular Disease, Digital Healthtech, Mass Population Health Screening.
What technology does CardiAction use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About CardiAction
CardiAction PreScreen: A non-invasive (no blood test required) mass population cardiovascular event risk assessment platform. How identifying the unidentified can reduce the impact of Cardiovascular Disease (CVD) on our populations and the health system. CardiAction ProScreen: An in-person, non-invasive cardiovascular risk assessment performed in pharmacies across Australia and New Zealand. Using advanced biometric telemetry and the CardiAction proprietary dynamic algorithm, ProScreen provides real-time insights into heart and artery health without the need for blood tests or radiation. Cardiovascular disease (CVD) is the #1 cause of death and continues to be responsible for 1/3rd of all deaths worldwide. Responsible for 44,000 deaths annually in Australia and 20 million globally. The Key Advantages of CardiAction The CardiAction Risk Score is a dynamic algorithm that integrates key biomarkers such as age, gender, height, waist circumference, heart rate, and blood pressure data. The model incorporates central systolic blood pressure (cSBP), a recognised predictor of cardiovascular events, such as heart attack and stroke. When using CardiAction PreScreen, cSBP is predicted with approximately ~80% accuracy based on self-reported and estimated biometrics. When using CardiAction ProScreen, cSBP is directly measured with ~99% accuracy in person using Pulse Wave Analysis (PWA). Both methods provide insight into arterial wall stiffness and inflammation. Research has shown that central blood pressure correlates more strongly with vascular disease and clinical outcomes than traditional brachial (arm) blood pressure.
Specialties
Where is CardiAction located?
CardiAction lists 3 office locations.
Compare companies similar to CardiAction
More companies in Hospitals and Health Care.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
CardiAction cardiaction.com | Hospitals and Health Care | 5 | 2017 | Melbourne, VIC |
Shockwave Medical jnj.com | Hospitals and Health Care | 132,911 | - | New Brunswick, NJ |
Spectranetics philips.com | Hospitals and Health Care | 72,819 | - | Amsterdam, Noord-Holland |
IQVIA iqvia.com | Hospitals and Health Care | 80,926 | - | Durham, North Carolina |
Unimed Nacional unimednacional.coop.br | Hospitals and Health Care | 5,279 | - | São Paulo, SP |
UnitedHealth Group unitedhealthgroup.com | Hospitals and Health Care | 91,204 | - | Eden Prairie , Minnesota, US |
Mayo Clinic mayoclinic.org | Hospitals and Health Care | 48,896 | - | Rochester, Minnesota |
Einstein Hospital Israelita einstein.br | Hospitals and Health Care | 41,193 | - | São Paulo, SP |
Johnson & Johnson MedTech jnjmedtech.com | Hospitals and Health Care | 37,860 | - | New Brunswick, New Jersey, US |
CVS Health cvshealth.com | Hospitals and Health Care | 140,340 | 1963 | Woonsocket, RI |
Kaiser Permanente kp.org | Hospitals and Health Care | 138,166 | 1945 | Oakland, California |
Frequently asked questions about CardiAction
What does CardiAction do?
CardiAction PreScreen: A non-invasive (no blood test required) mass population cardiovascular event risk assessment platform. How identifying the unidentified can reduce the impact of Cardiovascular Disease (CVD) on our populations and the health system. CardiAction ProScreen: An in-person, non-invasive cardiovascular risk assessment performed in pharmacies across Australia and New Zealand. Using advanced biometric telemetry and the CardiAction proprietary dynamic algorithm, ProScreen provides real-time insights into heart and artery health without the need for blood tests or radiation. Cardiovascular disease (CVD) is the #1 cause of death and continues to be responsible for 1/3rd of all deaths worldwide. Responsible for 44,000 deaths annually in Australia and 20 million globally. The Key Advantages of CardiAction The CardiAction Risk Score is a dynamic algorithm that integrates key biomarkers such as age, gender, height, waist circumference, heart rate, and blood pressure data. The model incorporates central systolic blood pressure (cSBP), a recognised predictor of cardiovascular events, such as heart attack and stroke. When using CardiAction PreScreen, cSBP is predicted with approximately ~80% accuracy based on self-reported and estimated biometrics. When using CardiAction ProScreen, cSBP is directly measured with ~99% accuracy in person using Pulse Wave Analysis (PWA). Both methods provide insight into arterial wall stiffness and inflammation. Research has shown that central blood pressure correlates more strongly with vascular disease and clinical outcomes than traditional brachial (arm) blood pressure.
How many employees does CardiAction have?
CardiAction has around 5 employees on LinkedIn.
Where is CardiAction headquartered?
CardiAction is headquartered in Melbourne, VIC.
Where does CardiAction have offices?
CardiAction lists 3 office locations, including Melbourne, VIC, AU; Brisbane, QLD, AU; Sydney, NSW, AU.
When was CardiAction founded?
CardiAction was founded in 2017.
Build a lead list from companies like CardiAction
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.